Filing/Prosecution and Patentshttp://www.managingip.com/RSS.aspx?FeedID=2910©2020 Managing Intellectual Property60Filing/Prosecution and PatentsAI inventorship denial not surprising but is step towards changeIn-house counsel from tech, automotive and pharmaceutical companies say it is business as usual after the EPO rejects AI inventor applications, but could be the start of long-term change to AI patent lawhttp://www.managingip.com/Article/3914230/AI-inventorship-denial-not-surprising-but-is-step-towards-change.htmlThu, 16 Jan 2020 14:00:00 GMTCannabis filers hash over FTO and future enforcementCounsel at Aphria, Cresco Labs, Aurora, Scientus Pharma and Canopy Growth say due diligence is becoming more important in their efforts to avoid infringement on copious new registrations, many of which are overly broad or hiddenhttp://www.managingip.com/Article/3914255/Cannabis-filers-hash-over-FTO-and-future-enforcement.htmlThu, 16 Jan 2020 14:00:00 GMTSEP remedy policy ‘reversal’ emboldens US patent ownersDespite having little legal impact, the Department of Justice’s and USPTO’s new joint policy statement on remedies for standard essential patents has encouraged many businesses in their FRAND negotiationshttp://www.managingip.com/Article/3914257/SEP-remedy-policy-reversal-emboldens-US-patent-owners.htmlThu, 16 Jan 2020 14:00:00 GMTUK SPC ruling pushes patent drafting specificityGenerics and innovator pharma companies welcome December’s SPC decision from a UK court, saying it further clarifies an uncertain regulation, but believe it will introduce prosecution challengeshttp://www.managingip.com/Article/3914231/UK-SPC-ruling-pushes-patent-drafting-specificity.htmlThu, 16 Jan 2020 14:00:00 GMTBIP Asia: AI-related IP policies need more work globallyPatentability and sufficiency of disclosure remain unsettled issues that IP owners and offices are grappling with, according to AIPPI and private practice speakershttp://www.managingip.com/Article/3913672/BIP-Asia-AI-related-IP-policies-need-more-work-globally.htmlMon, 13 Jan 2020 15:00:00 GMTSEP stakeholders want essentiality checks in 2020 to streamline negotiationsIn-house counsel say checks would be a good way to demonstrate that technologies are essential to a standard, but are not certain how they should be done or by which organisationhttp://www.managingip.com/Article/3912960/SEP-stakeholders-want-essentiality-checks-in-2020-to-streamline-negotiations.htmlThu, 09 Jan 2020 15:45:00 GMTLooking ahead to 2020: Lawyers contemplate key US patent casesPractitioners say that there could be significant IP shake-ups from the US Supreme Court, but that reform from Congress is unlikelyhttp://www.managingip.com/Article/3912931/Looking-ahead-to-2020-Lawyers-contemplate-key-US-patent-cases.htmlThu, 09 Jan 2020 15:15:00 GMTIn-house roundup: Fintech win worries financials; businesses look to 2020 essentiality checksManaging IP rounds up the latest news and analysis from in-house counselhttp://www.managingip.com/Article/3912978/In-house-roundup-Fintech-win-worries-financials-businesses-look-to-2020-essentiality-checks.htmlThu, 09 Jan 2020 15:00:00 GMTFirst patent win for bank puts financials on their toesA $200-million payment for USAA shows that financial companies are vulnerable to competitor patent claims and might need to build up their defensive portfolios, according to in-house counselhttp://www.managingip.com/Article/3912980/First-patent-win-for-bank-puts-financials-on-their-toes.htmlWed, 08 Jan 2020 16:00:00 GMTDepriving others of their intellectual propertyhttp://www.managingip.com/Article/3909913/Depriving-others-of-their-intellectual-property.htmlWed, 18 Dec 2019 15:00:00 GMTAI alliances will push pharma refocus on patent bundles and licensingPharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategieshttp://www.managingip.com/Article/3913010/AI-alliances-will-push-pharma-refocus-on-patent-bundles-and-licensing.htmlThu, 12 Dec 2019 16:30:00 GMTSeminal pay for delay law opposed by pharma companiesGenerics and innovator companies say they don’t like the new and ‘badly-worded’ legislation introduced by California that bans drug settlements and could actually raise drug priceshttp://www.managingip.com/Article/3913011/Seminal-pay-for-delay-law-opposed-by-pharma-companies.htmlThu, 12 Dec 2019 16:30:00 GMTIn-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaulManaging IP rounds up the latest news and analysis from patent-focused businesseshttp://www.managingip.com/Article/3908933/In-house-roundup-Pay-for-delay-opposed-by-all-AI-spurs-pharma-IP-refocus-energy-digitalisation-pushes.htmlThu, 12 Dec 2019 15:15:00 GMTIn-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fearManaging IP rounds up the latest news and analysis from patent-focused businesseshttp://www.managingip.com/Article/3907788/In-house-roundup-anti-anti-suit-injunction-filers-reveal-insights-US-UK-trade-documents-unpacked-open.htmlFri, 06 Dec 2019 09:00:00 GMTWhat the US-UK trade deal documents actually revealGenerics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patentshttp://www.managingip.com/Article/3913082/What-the-US-UK-trade-deal-documents-actually-reveal.htmlThu, 05 Dec 2019 17:00:00 GMTDismantling the patent system not a 'silver bullet' to lower drug pricesIn-house counsel from pharma innovators say the IP system is unfairly under attack for rising drug prices and that new drugs will not reach the market without patentshttp://www.managingip.com/Article/3913084/Dismantling-the-patent-system-not-a-silver-bullet-to-lower-drug-prices.htmlThu, 05 Dec 2019 12:00:00 GMTAnti-anti-suit injunctions: filers reveal importance of new ordersIPCom, Nokia and two car companies say the success of the new order shows that forum-shopping does not fly with European courts and – if that continues – anti-suit injunctions will not become popular as a ‘stalling tool’http://www.managingip.com/Article/3913081/Anti-anti-suit-injunctions-filers-reveal-importance-of-new-orders.htmlThu, 05 Dec 2019 11:45:00 GMTOpen source case prompts patent troll litigation fearsSoftware stakeholders including the Linux Foundation, Qualcomm and Unified Patents are concerned that RPI v Gnome has opened the door to open source NPE litigationhttp://www.managingip.com/Article/3913080/Open-source-case-prompts-patent-troll-litigation-fears.htmlThu, 05 Dec 2019 09:00:00 GMT50 most influential people in IP 2019: public officialsOur list includes 9 public officials, the details of which you can find below along with the full list of names that make up the Top 50http://www.managingip.com/Article/3907179/50-most-influential-people-in-IP-2019-public-officials.htmlWed, 04 Dec 2019 13:00:00 GMT50 most influential people in IP 2019: IP authoritiesOur list includes 8 IP authorities, the details of which you can find below along with the full list of names that make up the Top 50http://www.managingip.com/Article/3907174/50-most-influential-people-in-IP-2019-IP-authorities.htmlWed, 04 Dec 2019 12:15:00 GMTIn-house roundup: UPC: businesses still on hold; cooking up food patents; open data licences wanted; personalised medicine eligibilityManaging IP rounds up the latest news and analysis of patent-focused businesseshttp://www.managingip.com/Article/3906547/In-house-roundup-UPC-businesses-still-on-hold-cooking-up-food-patents-open-data-licences-wanted.htmlThu, 28 Nov 2019 15:15:00 GMTOpen data: tech companies seek better licencesWith the growing popularity of data development in the open source space, counsel at Red Hat, Microsoft and Benevolent AI say a mechanism is needed to enable better collaborationhttp://www.managingip.com/Article/3913086/Open-data-tech-companies-seek-better-licences.htmlThu, 28 Nov 2019 12:00:00 GMTPersonalised medicine is victim of US eligibilityUS Supreme Court decisions from the past decade have slowed down innovation in personalised medicine because of eligibility hurdles for diagnostic methods and gene sequencinghttp://www.managingip.com/Article/3913085/Personalised-medicine-is-victim-of-US-eligibility.htmlThu, 28 Nov 2019 12:00:00 GMTConsumable goods companies offer IP food for thoughtIP specialists from the food and tobacco industries reveal new ways patents are used to protect consumable goods and offer advice on how best to use trade secrets for protecting productshttp://www.managingip.com/Article/3913087/Consumable-goods-companies-offer-IP-food-for-thought.htmlWed, 27 Nov 2019 17:15:00 GMTUPC: businesses still on hold despite Judge Huber announcementSceptical of a UPC breakthrough, counsel at Bracco, Johnson & Johnson, Amadeus and elsewhere say they’re grateful for a timeframe, but that they won’t be ramping up preparations until the common system is closer to establishmenthttp://www.managingip.com/Article/3913089/UPC-businesses-still-on-hold-despite-Judge-Huber-announcement.htmlWed, 27 Nov 2019 17:00:00 GMTIn-house roundup: UPC report creates 'legal difficulty' for UK; auto embarks on patent strategy overhaul; Novartis chief wants IP system reformManaging IP rounds up the latest news and analysis on patent-focused businesseshttp://www.managingip.com/Article/3905370/In-house-roundup-UPC-report-creates-legal-difficulty-for-UK-auto-embarks-on-patent-strategy-overhaul.htmlThu, 21 Nov 2019 15:00:00 GMTTech convergence drives auto to burn up old strategiesThe new market dynamics in driverless cars are pushing car makers and suppliers to overhaul their patent strategies by building up portfolios and better positioning themselves for licensing negotiations and a potential patent warhttp://www.managingip.com/Article/3913091/Tech-convergence-drives-auto-to-burn-up-old-strategies.htmlThu, 21 Nov 2019 12:30:00 GMTEPO: In-house welcome opposition speed but want clearer BoA dataOppositions are speeding up but in-house lawyers say data on how successful appeals are at a higher level would have more practical significancehttp://www.managingip.com/Article/3905221/EPO-In-house-welcome-opposition-speed-but-want-clearer-BoA-data.htmlThu, 21 Nov 2019 09:15:00 GMTMost read 2019: Novartis chief wants industry balance and IP system reformIn an exclusive interview with Patent Strategy, IP head Galit Gonen-Cohen reveals her goals to better protect cell and gene therapies, ensure access to medicine and drive use of digital IP toolshttp://www.managingip.com/Article/3913092/Most-read-2019-Novartis-chief-wants-industry-balance-and-IP-system-reform.htmlThu, 21 Nov 2019 08:45:00 GMTMost read 2019: UPC report creates ‘point of legal difficulty’ for UK membershipAttorneys say ambiguity persists after a European Parliament report said UK membership of the UPC is a legal possibility after Brexit if the EU’s highest court maintains some jurisdiction over patent lawhttp://www.managingip.com/Article/3913094/Most-read-2019-UPC-report-creates-point-of-legal-difficulty-for-UK-membership.htmlThu, 21 Nov 2019 08:30:00 GMT